Market Currents

• Tuesday, November 3, 2009

• 08:40 AM Teva Pharmaceutical Industries (TEVA): Q3 EPS of $0.89 beats by $0.01. Revenue of $3.55B (-7.6%) vs. $3.63B. Shares -2% premarket. (PR) Comment!
• 00:05 AM Notable premarket earnings: ABC, ACOR, ADM, AMT, ANR, CAM, COL, CTSH, EMR, EXPD, FTR, GET, HCP, HNT, ICE, JOE, JRCC, LPX, MA, MHS, MRO, MVL, NXG, OSK, PER, PKD, PQ, RCL, RDC, RL, SNH, TE, TEVA, THC, TLM, VIA, VNO Comment!

• Wednesday, August 19, 2009

• 10:39 AM Courts uphold Merck's (MRK +1.7%) patent on its asthma drug, Singulair, dealing a blow to Teva Pharmaceutical (TEVA +0.8%), which had hoped to market a generic version before the patent expires in 2012. A generic would have blown a hole in Singulair's annual U.S. sales of $3B. Comment!

• Tuesday, July 28, 2009

• 07:00 AM Teva Pharmaceutical Industries (TEVA): Q2 EPS of $0.83 beats by $0.03. Revenue of $3.4B (+20%) vs. $3.5B. (PR) Comment!
• 00:05 AM Notable earnings before Tuesday's open: AMB, BEAV, BP, CE, CHKP, COH, CVH, DRH, ECL, ELNK, ENR, FPL, IPG, JEC, MHP, NOV, ODP, PCAR, PCX, ROK, SII, SVU, TEVA, TXT, VIA.B, VLO, VSH, WAT, WDR, X Comment!

• Tuesday, May 5, 2009

• 04:38 AM Teva Pharmaceutical Industries (TEVA): Q1 EPS of $0.71 beats by $0.03. Revenue of $3.1B (+22.4%) vs. $3.4B. (PR) Comment!
• 00:05 AM Notable earnings before Tuesday's open: ADM, ADP, ALU, AVP, AYE, BAM, CBB, CEG, CTSH, CVS, DNR, DRH, DUK, EMR, FCL, FE, HEW, HNT, ICE, JOE, KFT, LM, LPX, MAC, MVL, PAG, PCP, PGN, PNW, PQ, RDN, SE, SRE, TAP, TEVA, UNT, VRX, VTR, WEC, WTI, WY, WYNN, XEC
    Comment!

• Tuesday, February 17, 2009

• 05:55 AM Teva Pharmaceutical Industries (TEVA): Q4 EPS of $0.76 beats by $0.03. Revenue of $2.85B (+10.6%) vs. $2.9B. Shares -1.8% premarket. (PR) Comment!
• 00:05 AM Notable earnings before Tuesday's open: GPC, HOC, HSP, LPX, MDT, RIG, TEVA, WMT Comment!

• Thursday, November 6, 2008

• 00:05 AM Notable earnings before Thursday's open: ABH, ABV, AN, ANSS, ARD, BRL, BX, BZH, CCOI, CDL, CEG, CHTR, CLR, CXW, DPTR, DTV, DYN, EP, FLO, FTO, GOL, HK, HUN, IAG, INCY, JRCC, KG, LAMR, LINE, NDAQ, NRF, OMG, OMX, PCG, PNK, PRGO, SE, SFY, SNH, SONS, TEL, TEVA, TM, VCI, VRX, WEN, WMB, WNR, WRC Comment!

• Tuesday, August 26, 2008

• 06:59 AM Shares of Teva Pharmaceutical (TEVA) gain 1.1% in Tel Aviv after a phase-III trial of its Parkison's drug Azilect shows patients who began treatment immediately saw significant improvement compared to those who started treatment nine months later. Comment!

• Tuesday, July 29, 2008

• 06:53 AM Teva Pharmaceutical Industries (TEVA): Q2 EPS of $0.65 beats by $0.01. Revenue of $2.82B (+18.3%) vs. $2.68B. [PR] Comment!
• 00:05 AM Notable earnings before Tuesday's open: AAI, AG, ALU, ANR, ARM, BEAV, BMS, BP, CL, CLR, COH, ELNK, ETR, FDP, GM, GTI, HERO, IAR, IMA, JAH, LEA, LPX, MAS, MC, MHP, NCR, NOC, NOV, NRG, PPC, SAP, SEPR, TEVA, TLM, UA, VLO, VSH, WDR, WMI, X Comment!

• Friday, July 18, 2008

• 07:09 AM Teva (TEVA) is acquiring Barr Pharma (BRL) for $66.50/share ($7.46B) in cash and stock - a 42% premium to its Wednesday close. [PR] Comment!

• Thursday, July 17, 2008

• 11:55 AM Teva (TEVA -2%) to buy Barr Pharmaceuticals (BRL +16.3%) for $7-7.5B? Comment!

• Monday, July 7, 2008

• 15:46 PM Nasdaq leaders: YHOO +13.1%. HANS +12.8%. UAUA +10.4%. BRCM +8.1%. NTAP +5.9%. Nasdaq laggards: TEVA -9.7%. VRSN -7.7%. VMED -4.6%. SNDK -3.6%. Comment!